Drug
Lurasidone Hc1
Lurasidone Hc1: highest development phase Phase 3, developed by Sumitomo Pharma. 1 trial record tracked on RxWires.
- Highest phase
- Phase 3
- Developer
- Sumitomo Pharma
Trials
| Drug | Phase | Indication |
|---|---|---|
| Lurasidone HC1 NCT00789698 | Phase 3 | Chronic Schizophrenia |
Latest
No recent events.
Follow Lurasidone Hc1 on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.